Current treatment options in psoriasis

Hospital Practice

Volumn 35, Issue 7, 2000, Pages 93-107

  Khachemoune, Amor ^a,b   Phillips, Tania J ^a,b  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPSORIASIS AGENT; CALCIPOTRIOL; CLOBETASOL; COAL TAR; CORTICOSTEROID; CYCLOSPORIN; DITHRANOL; EMOLLIENT AGENT; ETRETIN; HYDROXYUREA; IMMUNOSUPPRESSIVE AGENT; KERATOLYTIC AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SALICYLIC ACID; TACROLIMUS; TAZAROTENE; TIOGUANINE; TOPICAL AGENT;

ARTICLE; BALNEOTHERAPY; DISEASE SEVERITY; HUMAN; PATHOPHYSIOLOGY; PHOTOTHERAPY; PSORIASIS; PUVA; SIDE EFFECT; ULTRAVIOLET B RADIATION;

EID: 0034661484     PISSN: 87502836     EISSN: None     Source Type: Journal    
DOI: 10.1080/21548331.2000.11444034     Document Type: Article

References (7)

1. Gordon PM et al. A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol 41:728, 1999
2. Greaves MW, Weinstein GD. Treatment of psoriasis. N Engl J Med 332:581, 1995
3. Saurat JH. Retinoids and psoriasis: Novel issues in retinoid pharmacology and implications for psoriasis treatment. J Am Acad Dermatol 41(Pt 2):S2, 1999
4. Stern RS, Lange R. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 91:120, 1988
5. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. N Engl J Med 336:1041, 1997
6. Stern RS et al. Contribution of topical tar oil to ultraviolet B phototherapy for psoriasis. J Am Acad Dermatol 14:742, 1986
7. Weinstein GD, White GM. An approach to the treatment of moderate to severe psoriasis with rotational therapy. J Am Acad Dermatol 28:454, 1993